JP2014500249A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500249A5 JP2014500249A5 JP2013537803A JP2013537803A JP2014500249A5 JP 2014500249 A5 JP2014500249 A5 JP 2014500249A5 JP 2013537803 A JP2013537803 A JP 2013537803A JP 2013537803 A JP2013537803 A JP 2013537803A JP 2014500249 A5 JP2014500249 A5 JP 2014500249A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- alopecia
- composition according
- subject
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40950910P | 2010-11-02 | 2010-11-02 | |
| US61/409,509 | 2010-11-02 | ||
| PCT/US2011/059029 WO2012061537A2 (en) | 2010-11-02 | 2011-11-02 | Methods for treating hair loss disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016114395A Division JP6259012B2 (ja) | 2010-11-02 | 2016-06-08 | 脱毛症の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014500249A JP2014500249A (ja) | 2014-01-09 |
| JP2014500249A5 true JP2014500249A5 (enExample) | 2014-12-18 |
| JP5948337B2 JP5948337B2 (ja) | 2016-07-06 |
Family
ID=46025096
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537803A Active JP5948337B2 (ja) | 2010-11-02 | 2011-11-02 | 脱毛症の治療方法 |
| JP2016114395A Active JP6259012B2 (ja) | 2010-11-02 | 2016-06-08 | 脱毛症の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016114395A Active JP6259012B2 (ja) | 2010-11-02 | 2016-06-08 | 脱毛症の治療方法 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2635299B1 (enExample) |
| JP (2) | JP5948337B2 (enExample) |
| KR (2) | KR101913293B1 (enExample) |
| CN (1) | CN103370076A (enExample) |
| DK (1) | DK2635299T3 (enExample) |
| ES (1) | ES2746554T3 (enExample) |
| HR (1) | HRP20191548T1 (enExample) |
| HU (1) | HUE045869T2 (enExample) |
| PL (1) | PL2635299T3 (enExample) |
| PT (1) | PT2635299T (enExample) |
| SI (1) | SI2635299T1 (enExample) |
| WO (1) | WO2012061537A2 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012061537A2 (en) * | 2010-11-02 | 2012-05-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating hair loss disorders |
| DK2830662T3 (da) * | 2012-03-29 | 2019-01-02 | Univ Columbia | Fremgangsmåder til behandlng af hårtabsforstyrrelser |
| WO2014013014A1 (en) * | 2012-07-18 | 2014-01-23 | Fundació Privada Centre De Regulació Genòmica (Crg) | Jak inhibitors for activation of epidermal stem cell populations |
| GB2536650A (en) | 2015-03-24 | 2016-09-28 | Augmedics Ltd | Method and system for combining video-based and optic-based augmented reality in a near eye display |
| CA2985185A1 (en) * | 2015-05-07 | 2016-11-10 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for promoting hair growth |
| MX2018001831A (es) * | 2015-08-14 | 2018-09-06 | Univ Columbia | Biomarcadores para el tratamiento de alopecia areata. |
| DE102015119880B4 (de) * | 2015-11-17 | 2018-05-24 | Technische Universität Berlin | Verfahren zur Herstellung von Haarfollikeln und de novo Papillen sowie deren Verwendung für in vitro Tests und in vivo Implantate |
| AR107195A1 (es) * | 2015-12-28 | 2018-03-28 | Natura Cosmeticos Sa | Composición lípida vegetal para promover el crecimiento del cabello, método para promover el crecimiento del cabello y uso de dichos lípidos vegetales |
| ES2988629T3 (es) * | 2016-05-04 | 2024-11-21 | Sun Pharmaceutical Ind Inc | Tratamiento de trastornos de pérdida de cabello con inhibidores de JAK deuterados |
| KR101657082B1 (ko) * | 2016-08-08 | 2016-09-13 | 에스씨엠생명과학 주식회사 | CXCL1(chemokine (C-X-C motif) ligand 1) 단백질을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물 |
| US10512670B2 (en) | 2016-08-08 | 2019-12-24 | Scm Lifescience Co., Ltd. | Pharmaceutical composition for preventing or treating hair loss comprising chemokine (C-X-C motif) ligand 1 (CXCL1) protein or CXCL1 protein and minoxidil as active ingredient |
| AU2018312349A1 (en) | 2017-08-01 | 2020-02-06 | Theravance Biopharma R&D Ip, Llc | Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors |
| JP6979582B6 (ja) * | 2017-09-22 | 2022-01-17 | 学校法人東海大学 | 変異型蛋白質、及び該変異型蛋白質を発現し円形脱毛を発症する遺伝子改変マウス |
| US12458411B2 (en) | 2017-12-07 | 2025-11-04 | Augmedics Ltd. | Spinous process clamp |
| US12521201B2 (en) | 2017-12-07 | 2026-01-13 | Augmedics Ltd. | Spinous process clamp |
| EP3787543A4 (en) | 2018-05-02 | 2022-01-19 | Augmedics Ltd. | REGISTRATION OF A FIDUCIAL MARKER FOR AN AUGMENTED REALITY SYSTEM |
| EP3801028A4 (en) | 2018-05-30 | 2022-04-13 | Direct Biologics LLC | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use |
| AU2019282155A1 (en) | 2018-06-04 | 2021-01-07 | Lars BRICHTA | Topical compositions for stimulating hair growth |
| US11766296B2 (en) | 2018-11-26 | 2023-09-26 | Augmedics Ltd. | Tracking system for image-guided surgery |
| US20220079990A1 (en) * | 2018-12-26 | 2022-03-17 | Direct Biologics Llc | Methods and compositions for treating skin and hair disorders |
| CN113498352A (zh) | 2019-01-23 | 2021-10-12 | 施万生物制药研发Ip有限责任公司 | 作为jak抑制剂的咪唑并[1,5-a]吡啶、1,2,4-三唑并[4,3-a]吡啶和咪唑并[1,5-a]吡嗪 |
| JP2022535178A (ja) * | 2019-01-30 | 2022-08-05 | ダイレクト バイオロジクス エルエルシー | 標的特異的エクソソームおよび増殖因子生成物を開発するための方法および組成物 |
| US12569517B2 (en) | 2019-02-07 | 2026-03-10 | Direct Biologics, Llc | Method for treating osteoarthritis with mesenchymal stem cell exosomes |
| US12213995B2 (en) | 2019-07-18 | 2025-02-04 | Direct Biologics, Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
| US12178666B2 (en) | 2019-07-29 | 2024-12-31 | Augmedics Ltd. | Fiducial marker |
| US11980506B2 (en) | 2019-07-29 | 2024-05-14 | Augmedics Ltd. | Fiducial marker |
| JP2021042161A (ja) * | 2019-09-11 | 2021-03-18 | 国立大学法人東海国立大学機構 | 脱毛剤、脱毛モデル動物及び白髪モデル動物 |
| US11697648B2 (en) | 2019-11-26 | 2023-07-11 | Theravance Biopharma R&D Ip, Llc | Fused pyrimidine pyridinone compounds as JAK inhibitors |
| US11382712B2 (en) | 2019-12-22 | 2022-07-12 | Augmedics Ltd. | Mirroring in image guided surgery |
| KR20230004709A (ko) | 2020-04-22 | 2023-01-06 | 다이렉트 바이오로직스 엘엘씨 | 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물 |
| US11389252B2 (en) | 2020-06-15 | 2022-07-19 | Augmedics Ltd. | Rotating marker for image guided surgery |
| US12239385B2 (en) | 2020-09-09 | 2025-03-04 | Augmedics Ltd. | Universal tool adapter |
| US12502163B2 (en) | 2020-09-09 | 2025-12-23 | Augmedics Ltd. | Universal tool adapter for image-guided surgery |
| US11896445B2 (en) | 2021-07-07 | 2024-02-13 | Augmedics Ltd. | Iliac pin and adapter |
| US12150821B2 (en) | 2021-07-29 | 2024-11-26 | Augmedics Ltd. | Rotating marker and adapter for image-guided surgery |
| CA3228505A1 (en) | 2021-08-11 | 2023-02-16 | Sun Pharmaceutical Industries, Inc. | Treatment of hair loss disorders with deuterated jak inhibitors |
| US12475662B2 (en) | 2021-08-18 | 2025-11-18 | Augmedics Ltd. | Stereoscopic display and digital loupe for augmented-reality near-eye display |
| WO2023203521A1 (en) | 2022-04-21 | 2023-10-26 | Augmedics Ltd. | Systems and methods for medical image visualization |
| CN116064461A (zh) * | 2022-08-12 | 2023-05-05 | 扬州大学 | Jak1蛋白泛素化位点在制备干扰素耐受细胞中的应用 |
| JP2025531829A (ja) | 2022-09-13 | 2025-09-25 | オーグメディックス リミテッド | 画像誘導医療介入のための拡張現実アイウェア |
| US12364699B2 (en) | 2023-10-10 | 2025-07-22 | Sun Pharmaceuticals Industries, Inc. | Method of treating hair loss disorders |
| US12502407B2 (en) | 2024-04-25 | 2025-12-23 | Direct Biologics, Llc | Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles |
| CN119746094A (zh) * | 2024-12-31 | 2025-04-04 | 深圳大学 | 脱毛化合物、动物脱毛模型及其制备方法与应用 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
| US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| US5879680A (en) | 1987-12-23 | 1999-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | Cloned DNA for synthesizing unique glucocerebrosidase |
| GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
| US5236838A (en) | 1988-12-23 | 1993-08-17 | Genzyme Corporation | Enzymatically active recombinant glucocerebrosidase |
| US6451600B1 (en) | 1989-12-22 | 2002-09-17 | Genzyme Corporation | Enzymatically active recombinant glucocerebrosidase |
| US5198346A (en) | 1989-01-06 | 1993-03-30 | Protein Engineering Corp. | Generation and selection of novel DNA-binding proteins and polypeptides |
| US5096815A (en) | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
| US5179023A (en) | 1989-03-24 | 1993-01-12 | Research Corporation Technologies, Inc. | Recombinant α-galactosidase a therapy for Fabry disease |
| US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| AU638762B2 (en) | 1989-10-05 | 1993-07-08 | Optein Inc | Cell-free synthesis and isolation of novel genes and polypeptides |
| DK0431519T3 (da) | 1989-12-04 | 1994-07-04 | Searle & Co | System til transdermal indgivelse af albuterol |
| US5747334A (en) | 1990-02-15 | 1998-05-05 | The University Of North Carolina At Chapel Hill | Random peptide library |
| US5401650A (en) | 1990-10-24 | 1995-03-28 | The Mount Sinai School Of Medicine Of The City University Of New York | Cloning and expression of biologically active α-galactosidase A |
| US6410010B1 (en) | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| CA2108144A1 (en) | 1991-03-06 | 1992-09-07 | Jack A. Roth | Methods and compositions for the selective inhibition of gene expression |
| US5352456A (en) | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
| US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| DE69228827T2 (de) | 1991-12-18 | 1999-10-21 | Minnesota Mining And Mfg. Co., Saint Paul | Mehrschichtige sperrstrukturen |
| ATE132381T1 (de) | 1992-01-29 | 1996-01-15 | Voelkl Franz Ski | Ballspielschläger, insbesondere tennisschläger |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| AU704183B2 (en) | 1994-01-05 | 1999-04-15 | Arqule, Inc. | Systematic modular production of aminimide- and oxazolone-based molecules having selected properties |
| US5712171A (en) | 1995-01-20 | 1998-01-27 | Arqule, Inc. | Method of generating a plurality of chemical compounds in a spatially arranged array |
| ES2264145T3 (es) | 1995-11-30 | 2006-12-16 | The Board Of Regents, The University Of Texas System | Metodos y composiciones para el tratamiento de cancer. |
| US6458574B1 (en) | 1996-09-12 | 2002-10-01 | Transkaryotic Therapies, Inc. | Treatment of a α-galactosidase a deficiency |
| US6083725A (en) | 1996-09-13 | 2000-07-04 | Transkaryotic Therapies, Inc. | Tranfected human cells expressing human α-galactosidase A protein |
| US7419661B2 (en) | 1997-04-30 | 2008-09-02 | The Centre Of Excellence For Life Sciences Limited | Dermal sheath tissue in wound healing |
| AR013269A1 (es) | 1997-08-04 | 2000-12-13 | Scras | Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral |
| US6210666B1 (en) | 1997-10-21 | 2001-04-03 | Orphan Medical, Inc. | Truncated α-galactosidase A to treat fabry disease |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| GB9827152D0 (en) | 1998-07-03 | 1999-02-03 | Devgen Nv | Characterisation of gene function using double stranded rna inhibition |
| CA2361201A1 (en) | 1999-01-28 | 2000-08-03 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
| DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| JP2003176273A (ja) * | 1999-02-10 | 2003-06-24 | Mitsubishi Pharma Corp | アミド化合物およびその医薬としての用途 |
| MXPA01008142A (es) * | 1999-02-10 | 2003-07-21 | Welfide Corp | Compuestos de amida, y uso medicinal de los mismos. |
| HK1047109A1 (zh) | 1999-10-15 | 2003-02-07 | University Of Massachusetts | 作为指定基因干预工具的rna干预轨迹基因 |
| GB9925964D0 (en) | 1999-11-03 | 1999-12-29 | Jahoda Colin A B | Hair transplantation |
| GB9927444D0 (en) | 1999-11-19 | 2000-01-19 | Cancer Res Campaign Tech | Inhibiting gene expression |
| US6188045B1 (en) | 2000-04-03 | 2001-02-13 | Alto-Shaam, Inc. | Combination oven with three-stage water atomizer |
| IES20010386A2 (en) | 2000-04-20 | 2001-11-14 | Bernard Mcnamara | A swimming pool assembly |
| US20030044803A1 (en) * | 2000-09-22 | 2003-03-06 | Pedersen Finn Skou | Methods for diagnosis and treatment of diseases associated with altered expression of JAK1 |
| US20020173478A1 (en) | 2000-11-14 | 2002-11-21 | The Trustees Of The University Of Pennsylvania | Post-transcriptional gene silencing by RNAi in mammalian cells |
| JP4205334B2 (ja) * | 2000-11-24 | 2009-01-07 | 株式会社 伊藤園 | 茶に由来する薬理組成物 |
| US7294504B1 (en) | 2001-12-27 | 2007-11-13 | Allele Biotechnology & Pharmaceuticals, Inc. | Methods and compositions for DNA mediated gene silencing |
| US7148342B2 (en) | 2002-07-24 | 2006-12-12 | The Trustees Of The University Of Pennyslvania | Compositions and methods for sirna inhibition of angiogenesis |
| DK1563061T3 (da) | 2002-11-14 | 2012-10-01 | Aderans Res Inst Inc | Dyrkning af hårinducerende celler |
| US7884189B2 (en) | 2003-01-10 | 2011-02-08 | The Trustees Of Columbia University In The City Of New York | Carboxyltransferase domain of acetyl-CoA carboxylase |
| AU2006242154B2 (en) | 2005-05-02 | 2011-11-03 | Cold Spring Harbor Laboratory | Composition and methods for cancer diagnosis utilizing the mir 17-92 cluster |
| US9109204B2 (en) | 2006-02-28 | 2015-08-18 | The Trustees Of Columbia University In The City Of New York | Methods for compact aggregation of dermal cells |
| US9486524B2 (en) * | 2006-09-01 | 2016-11-08 | Genticel | Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| CL2008001709A1 (es) * | 2007-06-13 | 2008-11-03 | Incyte Corp | Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras. |
| KR20150036210A (ko) * | 2007-06-13 | 2015-04-07 | 인사이트 코포레이션 | 야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염 |
| EP2274288A2 (en) * | 2008-04-24 | 2011-01-19 | Incyte Corporation | Macrocyclic compounds and their use as kinase inhibitors |
| WO2010093808A1 (en) * | 2009-02-11 | 2010-08-19 | Reaction Biology Corp. | Selective kinase inhibitors |
| WO2012061537A2 (en) * | 2010-11-02 | 2012-05-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating hair loss disorders |
-
2011
- 2011-11-02 WO PCT/US2011/059029 patent/WO2012061537A2/en not_active Ceased
- 2011-11-02 DK DK11838771.1T patent/DK2635299T3/da active
- 2011-11-02 KR KR1020137014155A patent/KR101913293B1/ko active Active
- 2011-11-02 KR KR1020187030745A patent/KR102027394B1/ko active Active
- 2011-11-02 ES ES11838771T patent/ES2746554T3/es active Active
- 2011-11-02 EP EP11838771.1A patent/EP2635299B1/en active Active
- 2011-11-02 CN CN2011800637870A patent/CN103370076A/zh active Pending
- 2011-11-02 HU HUE11838771A patent/HUE045869T2/hu unknown
- 2011-11-02 HR HRP20191548TT patent/HRP20191548T1/hr unknown
- 2011-11-02 SI SI201131778T patent/SI2635299T1/sl unknown
- 2011-11-02 PT PT118387711T patent/PT2635299T/pt unknown
- 2011-11-02 JP JP2013537803A patent/JP5948337B2/ja active Active
- 2011-11-02 PL PL11838771T patent/PL2635299T3/pl unknown
-
2016
- 2016-06-08 JP JP2016114395A patent/JP6259012B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014500249A5 (enExample) | ||
| Fan et al. | MicroRNA-210 promotes angiogenesis in acute myocardial infarction | |
| CY1124327T1 (el) | Τροποποιηση της εκφρασης του ιου ηπατιτιδας β (hbv) | |
| UA108193C2 (uk) | Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань | |
| EA202090338A1 (ru) | Функционально-модифицированные олигонуклеотиды и их субъединицы | |
| BR112021024786A2 (pt) | Construção de rna, sequência de ácido nucleico, cassete de expressão, vetor recombinante, composição farmacêutica, método para preparar a construção de rna, vacina, método para modificar uma célula ex vivo ou in vitro e célula modificada | |
| MX373926B (es) | Metodos para tratar cancer y estados no neoplasicos. | |
| BR112014007086A2 (pt) | proteínas de função dual para o tratamento de distúrbios metabólicos | |
| BR112014007069A2 (pt) | proteínas de fusão para o tratamento de distúrbios metabólicos | |
| BR112015009559A2 (pt) | uso de composto antissenso na preparação de medicamento para tratamento de cãncer, composto antissenso e composição farmacêutica | |
| BR112014023898A2 (pt) | moléculas de ácido nucleico artificiais compreendendo 5''utr top | |
| BR112014011896A2 (pt) | agentes de rnai, composições e métodos de uso destes para o tratamento de doenças associadas à transtirretina (ttr) | |
| MX385869B (es) | Agentes de iarn modificados. | |
| EA202191537A1 (ru) | Композиции и способы ингибирования экспрессии генов вируса гепатита в | |
| JP2014501492A5 (enExample) | ||
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| WO2008115851A3 (en) | Rnai therapeutic for respiratory virus infection | |
| BR112014032316A2 (pt) | proteínas de repetição de anquirina projetadas que se ligam ao fator de crescimento derivado de plaqueta | |
| MX2013009191A (es) | Oligonucleotidos antisentido. | |
| BRPI0515646A8 (pt) | Proteína de fusão e formulação farmacêutica | |
| EA201490654A1 (ru) | Новые ингибиторы вирусной репликации | |
| MX2009008118A (es) | Polipeptido e2 del virus del papiloma usado para vacunacion. | |
| Zhang et al. | An aptamer targets HBV core protein and suppresses HBV replication in HepG2. 2.15 cells | |
| BR112014010134A2 (pt) | inibição da expressão genética viral | |
| BRPI0513819A (pt) | inibidores de hsp90 |